DR ANGELA SHEU
About
Dr Angela Sheu graduated with a combined Bachelor of Medicine and Surgery (Honours) and Bachelor of Science (Medicine) Honours from the University of New South Wales, and completed Endocrinology training at St George, Prince of Wales and St Vincent’s hospitals.
​
She is currently appointed as a Staff Specialist Endocrinologist at St Vincent's Hospital. Her PhD on the topic of bone health in type 2 diabetes and metabolic syndromes received the Best Thesis Award at the Garvan Institute of Medical Research.
She is experienced in managing complex endocrine disorders, including pituitary disease, endocrine disease in pregnancy and pre-conception, and peri-operative management of endocrine disorders. Her research focuses on osteoporosis and diabetes mellitus, although she is interested in all aspects of endocrinology, including insulin resistance and Polycystic Ovarian Syndrome, thyroid, pituitary and adrenal disorders.
She is also a Conjoint Lecturer with the Faculty of Medicine at University of New South Wales, where she is involved in teaching medical students and training specialist Registrars.
Dr Sheu has published in numerous peer-reviewed journals, and has presented at multiple national bone, diabetes, endocrine, and general physician conferences.
She has received awards from National Health and Medical Research Council (NHMRC), Diabetes Australia, Osteoporosis Australia, Royal Australasian College of Physicians (RACP) and the University of New South Wales (UNSW). In 2015, she was awarded the Graz Clock Award for Best Oral Presentation at Australian Diabetes in Pregnancy Society (ADIPS) scientific meeting, and in 2016 she won the NSW Trainee Research Award in Adult Medicine by the RACP.
She regularly attends national and international meetings in order to provide her patients with up to date and evidence-based, comprehensive individualised care. She is a member of multiple national and international societies (Australian Diabetes Society, Endocrine Society Australia, Australian Diabetes in Pregnancy Society, Australian and New Zealand Bone and Mineral Society and American Society for Bone and Mineral Research).
Dr Sheu is compassionate and dedicated to patient care, teaching, and research. She is committed to providing personalised, evidence-based quality care that considers the patient’s goals and preferences in their clinical management.
Publications
Sheu A, Blank RD, Tran T, Bliuc D, Greenfield JR, White CP, Center JR.
Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study. JBMR Plus. 2023;e10780. doi:10.1002/jbm4.10780.
Sheu A, O'Connell RL, Jenkins AJ, Tran T, Drury PL, Sullivan DR, Li L, Colman P, O'Brien R, Kesäniemi YA, Center JR, White CP, Keech AC. (2023), Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Metab Res Rev. 2023;39(5):e3631. doi:10.1002/dmrr.3631
Sheu A, Greenfield JR, White CP, Center JR.
(2023), Contributors to impaired bone health in type 2 diabetes. Trends Endocrinol Metab. 34(1):34-48. doi:10.1016/j.tem.2022.11.003.
Sheu A, Greenfield JR, White CP, Center JR.
(2022), Assessment and treatment of osteoporosis and fractures in type 2 diabetes. Trends Endocrinol Metab. 33(5):333-344. doi:10.1016/j.tem.2022.02.006.
Sheu A, Bliuc D, Tran T, White CP, Center JR.
(2022), Fractures in type 2 diabetes confer excess mortality: The Dubbo osteoporosis epidemiology study. Bone. 159:116373. doi:10.1016/j.bone.2022.116373. PMID: 35231635.
Sheu A, Tonks KT.
Bone health in type 2 diabetes. Managing fracture risk. Endocrinology Today 2021; 10(1): 6-11.
Sheu A, Chan, Y, Ferguson, A et al.
(2018), A proinflammatory CD4+ T cell phenotype in gestational diabetes mellitus. Diabetologia, https://doi.org/10.1007/s00125-018-4615-1
Sheu A, Lopes LBA, Eisman J and Center, JR.
(2017), Osteoporosis management in 2017: still thin and fragmented. Intern Med J, 47: 1329–1330.
Sheu A and Center J.
(2017). Osteoporosis in postmenopausal women: key aspects of prevention and treatment. Medicine Today, 18(4)29-38.
Munoz MA, Jurczyluk J, Mehr S, Chai RC, Arts RJW, Sheu A, McMahon C, Center JR, Singh-Grewal D, Chaitow J, Campbell DE, Quinn JMW, Alexandrov K, Tnimov Z, Tangye SG, Simon A, Phan TG & Rogers MJ
(2017). Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency. J Allergy Clin Immunol, 140(3):873-875.e6.
Sheu A, Depczynski B, O'Sullivan AJ, Luxton G and Mangos G.
(2016). The Effect of Different Glycaemic States on Renal Transplant Outcomes. J Diabetes Res. 2016:8735782. Epub 2016 Dec 7.
Sheu A and Depczynski B.
(2016). Post-transplant diabetes mellitus (PTDM) – what is the literature? What do Primary Care Specialists need to know and how does it affect clinical management? Diabetes Management Journal, 55:24-26.
Sheu A and Diamond T.
(2016). Secondary Osteoporosis. Australian Prescriber, 39(3):85-87.
Sheu A and Diamond T.
(2016). Bone mineral density: testing for osteoporosis. Australian Prescriber, 39(2):35-9.
Sheu A and Diamond T.
(2016). Osteosclerosis: a patient with bone pain and increased bone mass. Endocrinology Today, 5(1):20-24.
Mann SA, Castro ML, Ohanian M, Guo G, Zodgekar P, Sheu A, Stockhammer K, Thompson T, Playford D, Subbiah R, Kuchar D, Aggarwal A, Vandenberg JI & Fatkin D.
(2012). R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. Journal of the American College of Cardiology, 60(16):1566-1573.
Yeoh T, Hayward C, Benson V, Sheu A, Richmond Z, Feneley MP, Keogh AM, Macdonald PS & Fatkin D.
(2011). A randomised, placebo-controlled trial of carvedilol in early familial dilated cardiomyopathy. Heart, Lung and Circulation, 20(9):566-573.
Fatkin D, Yeoh T, Hayward CS, Benson V, Sheu A, Richmond Z, Feneley MP, Keogh AM, & Macdonald PS
(2011). Evaluation of Left Ventricular Enlargement as a Marker of Early Disease in Familial Dilated Cardiomyopathy: Clinical Perspective. Circulation: Cardiovascular Genetics, 4(4):342-348.
Presentations​
Sheu A, O’Connell R, Jenkins A, Center JR, White CP, Keech A.
Fractures in T2DM independently predicted by insulin use and vascular complications (FIELD study). 2020 ADS Australasian Diabetes Congress.
​
Sheu A, O’Connell R, Jenkins A, Center JR, White CP, Keech A.
Fractures in T2DM independently predicted by insulin use and vascular complications (FIELD study). 2020 ANZBMS Annual Scientific Meeting. Finalist for ANZBMS Roger Mellick Young Investigator Award.
​
Sheu A, O’Connell R, Jenkins A, Center JR, White CP, Keech A.
Fractures in T2DM independently predicted by insulin use and vascular complications (FIELD study). 2020 ESA Annual Scientific Meeting. Finalist for Best of the Best E-Poster.
​
Sheu A.
Targeting therapies: treating disease of the bone. 2018 Garvan Public Seminar: Bone Biology.
​
Sheu A.
Osteoporosis: Current prevention and management principles. 2018 Australasian Faculty of Rehabilitation Medicine NSW Lecture Series, Sydney.
​
Sheu A, Bliuc D, Eisman JA, White C, Greenfield JR, Center J.
Visceral fat and insulin resistance is associated with lower bone turnover. 2018 St Vincent’s Campus Research Symposium.
​
Sheu A.
Fracture in Type 2 Diabetes Confers Excess Mortality. 2018 St Vincent’s Campus Research Week. Winner of Chair’s Choice Award for Fast Forward Oral Presentation.
​
Sheu A, Bliuc D, Alarkawi D, Alajlouni D, Tonks K, Samocha-Bonet D, Eisman JA, White C, Greenfield JR, Center J.
Excess prevalent clinical vertebral fractures and increased mortality following fracture in T2DM despite preserved bone mineral density. 2018 ADS/ADEA Australasian Diabetes Congress, Adelaide. Finalist for ADS President’s Young Investigator Award.
​
Sheu A, Bliuc D, Alarkawi D, Alajlouni D, Tonks K, Samocha-Bonet D, Eisman JA, White C, Greenfield JR, Center J.
Visceral fat and insulin resistance is associated with lower bone turnover. 2018 ADS/ADEA Australasian Diabetes Congress, Adelaide. Awarded ADS Travel Grant.
​
Sheu A, Bliuc D, Eisman JA, Greenfield JR, White C, Center J.
Fracture in type 2 diabetes confers excess mortality. 2018 International Osteoporosis Foundation Regional 7th Asia-Pacific Osteoporosis Conference, Sydney, Australia.
​
Sheu A, Bliuc D, Eisman JA, Greenfield JR, White C, Center J.
Visceral fat and insulin resistance are associated with lower bone turnover. 2018 International Osteoporosis Foundation Regional 7th Asia-Pacific Osteoporosis Conference, Sydney, Australia.
​
Sheu A, Bliuc D, Alarkawi D, Alajlouni D, Tonks K, Samocha-Bonet D, Eisman JA, Greenfield JR, White C, Center J.
Fracture in Type 2 Diabetes Confers Excess Mortality. 2018 St Vincent’s Campus Research Symposium. Awarded Poster Award (runner up).
​
Sheu A, Bliuc D, Alarkawi D, Alajlouni D, Tonks K, Samocha-Bonet D, Eisman JA, Greenfield JR, White C, Center J.
Visceral fat and insulin resistance is associated with lower bone turnover. 2018 ANZBMS Annual Scientific Meeting. Awarded ANZBMS Travel Grant.
Sheu A, Bliuc D, Alarkawi D, Alajlouni D, Tonks K, Samocha-Bonet D, Eisman JA, Greenfield JR, White C, Center J.
Excess prevalent clinical vertebral fractures and increased mortality following fracture in T2DM despite preserved bone mineral density. 2018 ANZBMS Annual Scientific Meeting.
​
Sheu A.
Diabetes and Bone. 2016 ANZBMS Advanced Clinical Postgraduate Meetings in Bone Disease, Sydney.
​
Sheu A, Chan YX, Bakhtyari M, Palendira U, Bertolino P, Chan YF, White C, Sierro F, Lau SM.
The pro-inflammatory T cell phenotype in Gestational Diabetes and the postpartum period. 2016 RACP Trainee Research Awards in Adult Medicine, Sydney. Winner of NSW.
​
Sheu A, Center J, Elder G.
Persistent hyperparathyroidism following renal transplantation: where to now? ESA/ANZBMS 2016 Annual Scientific Meeting, Gold Coast. Awarded ANZBMS Travel Grant.
Sheu A, Center J, Elder G.
How low can you go: bone metabolism in chronic kidney disease. ESA/ANZBMS 2016 Annual Scientific Meeting.
​
Sheu A, Chan YX, Bakhtyari M, Palendira U, Bertolino P, Chan YF, White C, Sierro F, Lau SM.
The pro-inflammatory T cell phenotype in Gestational Diabetes and the postpartum period. ADIPS 2015 Annual Scientific Meeting, Adelaide. Winner of Graz Clock Award. Awarded ADIPS Travel Grant.
​
Sheu A, Ng B, Fu K, Mangos G, Depczynski B.
Impact of Diabetes Mellitus and New Onset Diabetes After Transplant on outcomes after Renal Transplantation. ADS/ADEA 2015 Annual Scientific Meeting, Adelaide. Awarded ADS Travel Grant.
Sheu A, Ng B, Fu K, Mangos G, Depczynski B.
Outcomes after Renal Transplantation in Diabetes and New Onset of Diabetes After Transplantation. 2015 Prince of Wales Hospital TOW Awards, Sydney.
Jones J, Fu K, Ng B, Sheu A, Mangos G, Luxton G, Depczynski B.
Predictors of New Onset Diabetes Mellitus (NODAT) After Renal Transplantation. ADS/ADEA 2015 Annual Scientific Meeting.
​
Sheu A, Diamond T.
A Hard Case to Crack. Case presentation and literature review. 2014 ESA Clinical Weekend.